Recruiting
Phase 2

Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

Sponsor:

Transparency Life Sciences

Code:

NCT02369926

Conditions

Multiple Sclerosis, Relapsing-Remitting

Eligibility Criteria

Sex: All

Age: 18 - 64

Healthy Volunteers: Not accepted

Interventions

Multiple Sclerosis Functional Composite

Mobile Multiple Sclerosis Functional Composite

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information